SignalXSignalX

Tvardi Therapeutics, Inc. (TVRD) 8-K Current Report: March 6, 2026

Filed: March 6, 2026
Health Care
Pharmaceutical Preparations
Tvardi Therapeutics, Inc. Overview

Tvardi Therapeutics, Inc. (TVRD) 8-K current report filed with SEC EDGAR on March 6, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 8.01: Other Events

Tvardi Therapeutics, Inc. 8-K Mar 6, 2026 Event Analysis

Item 8.01 · Other Events

  • • 2026 Annual Meeting set for June 9, 2026
  • • Rule 14a-8 stockholder proposal deadline: March 16, 2026
  • • Advance notice deadline for board nominations and other proposals: March 16, 2026
  • • Universal proxy rule (Rule 14a-19) notice deadline for contested director nominations: April 10, 2026

Get deeper insights on Tvardi Therapeutics, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.